keyword
https://read.qxmd.com/read/38647550/suppression-of-type-i-interferon-signaling-in-myeloid-cells-by-autoantibodies-in-severe-covid-19-patients
#1
JOURNAL ARTICLE
Ami Aoki, Chiaki Iwamura, Masahiro Kiuchi, Kaori Tsuji, Atsushi Sasaki, Takahisa Hishiya, Rui Hirasawa, Kota Kokubo, Sachiko Kuriyama, Atsushi Onodera, Tadanaga Shimada, Tetsutaro Nagaoka, Satoru Ishikawa, Akira Kojima, Haruki Mito, Ryota Hase, Yasunori Kasahara, Naohide Kuriyama, Sukeyuki Nakamura, Takashi Urushibara, Satoru Kaneda, Seiichiro Sakao, Osamu Nishida, Kazuhisa Takahashi, Motoko Y Kimura, Shinichiro Motohashi, Hidetoshi Igari, Yuzuru Ikehara, Hiroshi Nakajima, Takuji Suzuki, Hideki Hanaoka, Taka-Aki Nakada, Toshiaki Kikuchi, Toshinori Nakayama, Koutaro Yokote, Kiyoshi Hirahara
PURPOSE: Auto-antibodies (auto-abs) to type I interferons (IFNs) have been identified in patients with life-threatening coronavirus disease 2019 (COVID-19), suggesting that the presence of auto-abs may be a risk factor for disease severity. We therefore investigated the mechanism underlying COVID-19 exacerbation induced by auto-abs to type I IFNs. METHODS: We evaluated plasma from 123 patients with COVID-19 to measure auto-abs to type I IFNs. We performed single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells from the patients with auto-abs and conducted epitope mapping of the auto-abs...
April 22, 2024: Journal of Clinical Immunology
https://read.qxmd.com/read/38647528/a-bispecific-antibody-that-targets-the-membrane-proximal-region-of-mesothelin-and-retains-high-anticancer-activity-in-the-presence-of-shed-mesothelin
#2
JOURNAL ARTICLE
Anirban Chakraborty, Masanori Onda, Tara O'Shea, Junxia Wei, Xiufen Liu, Tapan K Bera, Ira Pastan
Mesothelin (MSLN) is a cell-surface protein that is expressed on many cancers, which makes it a popular target for antibody-based cancer therapy. However, MSLN is shed from cancer cells at high levels via proteases that cleave at its membrane-proximal C-terminal region. Shed MSLN accumulates in patient fluids and tumors and can block antibody-based MSLN-targeting drugs from killing cancer cells. A previously established monoclonal antibody (mAb), 15B6, binds MSLN at its protease-sensitive C-terminal region and does not bind shed MSLN...
April 22, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38647139/localization-of-g1a1a-allergenic-domain-destroyed-by-thermal-processing
#3
JOURNAL ARTICLE
Tianjiao Shui, Yang Fu, Yuying Duan, Fuyu Sun, Huanhuan Yang, Pengbo Huang, Jun Xi
Glycinin is an important allergenic protein. A1a is the acidic chain of the G1 subunit in glycinin (G1A1a), and it has strong allergenicity. In this study, we used phage display technology to express the protein of G1A1a and its overlapping fragments and an indirect enzyme-linked immunosorbent assay (iELISA) to determine the antigenicity and allergenicity of the expressed protein. After three rounds of screening, it was determined that fragment A1a-2-B-I (151 SLENQLDQMPRRFYLAGNQEQEFLKYQQEQG181 ) is the allergenic domain of G1A1a destroyed by thermal processing...
April 22, 2024: Journal of Agricultural and Food Chemistry
https://read.qxmd.com/read/38646540/mhcii-peptide-presentation-an-assessment-of-the-state-of-the-art-prediction-methods
#4
REVIEW
Yaqing Yang, Zhonghui Wei, Gabriel Cia, Xixi Song, Fabrizio Pucci, Marianne Rooman, Fuzhong Xue, Qingzhen Hou
Major histocompatibility complex Class II (MHCII) proteins initiate and regulate immune responses by presentation of antigenic peptides to CD4+ T-cells and self-restriction. The interactions between MHCII and peptides determine the specificity of the immune response and are crucial in immunotherapy and cancer vaccine design. With the ever-increasing amount of MHCII-peptide binding data available, many computational approaches have been developed for MHCII-peptide interaction prediction over the last decade...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38644999/virus-like-particle-vlp-based-vaccine-targeting-tau-phosphorylated-at-ser396-ser404-phf1-site-outperforms-phosphorylated-s199-s202-at8-site-in-reducing-tau-pathology-and-restoring-cognitive-deficits-in-the-rtg4510-mouse-model-of-tauopathy
#5
Jonathan Hulse, Nicole Maphis, Julianne Peabody, Bryce Chackerian, Kiran Bhaskar
Tauopathies, including Alzheimer's disease (AD) and Frontotemporal Dementia (FTD), are histopathologically defined by the aggregation of hyperphosphorylated pathological tau (pTau) as neurofibrillary tangles in the brain. Site-specific phosphorylation of tau occurs early in the disease process and correlates with progressive cognitive decline, thus serving as targetable pathological epitopes for immunotherapeutic development. Previously, we developed a vaccine (Qβ-pT181) displaying phosphorylated Thr181 tau peptides on the surface of a Qβ bacteriophage virus-like particle (VLP) that induced robust antibody responses, cleared pathological tau, and rescued memory deficits in a transgenic mouse model of tauopathy...
April 9, 2024: bioRxiv
https://read.qxmd.com/read/38643839/fusobacterium-nucleatum-carcinogenesis-and-drug-delivery-interventions
#6
REVIEW
Zhenzhen Chen, Leaf Huang
The microbiome has emerged as a significant biomarker and modulator in cancer development and treatment response. Recent research highlights the notable role of Fusobacterium nucleatum (F. nucleatum) in various tumor types, including breast, colorectal, esophageal, gastric, pancreatic, and lung cancers. Accumulating evidence suggests that the local microbial community forms an integral component of the tumor microenvironment, with bacterial communities within tumors displaying specificity to tumor types. Mechanistic investigations indicate that tumor-associated microbiota can directly influence tumor initiation, progression, and responses to chemotherapy or immunotherapy...
April 19, 2024: Advanced Drug Delivery Reviews
https://read.qxmd.com/read/38643541/tumor-associated-carbohydrate-antigens-of-muc1-implication-in-cancer-development
#7
REVIEW
Iwona Radziejewska
Glycosylation of cancerous epithelial MUC1 protein is specifically altered in comparison to that which is presented by healthy cells. One of such changes is appearing tumor-associated carbohydrate antigens (TACAs) which are rare in normal tissues and are highly correlated with poor clinical outcomes and cancer progression. This review summarizes and describes the role of Tn, T antigens, their sialylated forms as well as fucosylated Lewis epitopes in different aspects of tumor development, progression, and metastasis...
April 20, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38643540/a-rational-designed-multi-epitope-vaccine-elicited-robust-protective-efficacy-against-klebsiella-pneumoniae-lung-infection
#8
JOURNAL ARTICLE
Jingwen Liao, Xiaoli Zhang, Xi Zeng, Zhuo Zhao, Tianjun Sun, Zhenping Xia, Haiming Jing, Yue Yuan, Zhifu Chen, Qiang Gou, Liqun Zhao, Weijun Zhang, Quanming Zou, Jinyong Zhang
BACKGROUND: The emergence of drug-resistant strains of Klebsiella pneumoniae (K. pneumoniae) has become a significant challenge in the field of infectious diseases, posing an urgent need for the development of highly protective vaccines against this pathogen. METHODS AND RESULTS: In this study, we identified three immunogenic extracellular loops based on the structure of five candidate antigens using sera from K. pneumoniae infected mice. The sequences of these loops were linked to the C-terminal of an alpha-hemolysin mutant (mHla) from Staphylococcus aureus to generate a heptamer, termed mHla-EpiVac...
April 20, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38642787/decellularized-kidney-extracellular-matrix-based-hydrogels-for-renal-tissue-engineering
#9
JOURNAL ARTICLE
Rita Quinteira, Sara Gimondi, Nelson O Monteiro, Rita Sobreiro-Almeida, Laura Lasagni, Paola Romagnani, Nuno M Neves
Kidney regeneration is hindered by the limited pool of intrinsic reparative cells. Advanced therapies targeting renal regeneration have the potential to alleviate the clinical and financial burdens associated with kidney disease. Delivery systems for cells, extracellular vesicles, or growth factors aimed at enhancing regeneration can benefit from vehicles enabling targeted delivery and controlled release. Hydrogels, optimized to carry biological cargo while promoting regeneration, have emerged as promising candidates for this purpose...
April 18, 2024: Acta Biomaterialia
https://read.qxmd.com/read/38642684/a-highly-efficient-blocking-elisa-based-on-p72-monoclonal-antibody-for-the-detection-of-african-swine-fever-virus-antibodies-and-identification-of-its-linear-b-cell-epitope
#10
JOURNAL ARTICLE
Weldu Tesfagaber, Wan Wang, Lulu Wang, Rui Zhao, Yuanmao Zhu, Fang Li, Encheng Sun, Renqiang Liu, Zhigao Bu, Geng Meng, Dongming Zhao
Due to the absence of effective vaccine and treatment, African swine fever virus (ASFV) control is entirely dependent on accurate and early diagnosis, along with culling of infected pigs. The B646L/p72 is the major capsid protein of ASFV and is an important target for developing a diagnostic assays and vaccines. Herein, we generated a monoclonal antibody (mAb) (designated as 2F11) against the trimeric p72 protein, and a blocking ELISA (bELISA) was established for the detection of both genotype I and II ASFV antibodies...
April 18, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38641833/stability-and-integrity-of-self-assembled-bovine-parvovirus-virus%C3%A2-like-particles-bpv%C3%A2-vlps-of-vp2-and-combination-of-vp1vp2-assisted-by-baculovirus-insect-cell-expression-a-potential-logistical-platform-for-vaccine-deployment
#11
JOURNAL ARTICLE
Ashenafi Kiros Wubshet, Guo-Xiu Li, Qian Li, Jun-Fei Dai, Yao-Zhong Ding, Luoyi Zhou, Min Qu, Yang Wang, Zhongyuan Ma, Gebremeskel Mamu Werid, Birhanu Hadush Abera, Asmelash Tassew Kebede, Yuefeng Sun, Xiangping Yin, Yongsheng Liu, Zhang Jie
BACKGROUND: Bovine parvovirus (BPV) is an autonomous DNA virus with a smaller molecular size and subtle differences in its structural proteins, unlike other animal parvoviruses. More importantly, this virus has the potential to produce visible to silent economic catastrophes in the livestock business, despite receiving very little attention. Parvoviral virus-like particles (VLPs) as vaccines and as logistical platforms for vaccine deployment are well studied. However, no single experimental report on the role of VP1 in the assembly and stability of BPV-VLPs is available...
April 19, 2024: Virology Journal
https://read.qxmd.com/read/38641595/design-of-a-multi-epitope-based-vaccine-candidate-against-bovine-genital-campylobacteriosis-using-a-reverse-vaccinology-approach
#12
JOURNAL ARTICLE
Marta Filipa Silva, Gonçalo Pereira, Luísa Mateus, Luís Lopes da Costa, Elisabete Silva
BACKGROUND: Bovine Genital Campylobacteriosis (BGC), a worldwide distributed venereal disease caused by Campylobacter fetus subsp. venerealis (Cfv), has a relevant negative economic impact in cattle herds. The control of BGC is hampered by the inexistence of globally available effective vaccines. The present in silico study aimed to develop a multi-epitope vaccine candidate against Cfv through reverse vaccinology. RESULTS: The analysis of Cfv strain NCTC 10354 proteome allowed the identification of 9 proteins suitable for vaccine development...
April 19, 2024: BMC Veterinary Research
https://read.qxmd.com/read/38641176/mesothelin-car-t-cells-expressing-tumor-targeted-immunocytokine-il-12-yield-durable-efficacy-and-fewer-side-effects
#13
JOURNAL ARTICLE
Yuankui Zhu, Ke Wang, Linghe Yue, Dianbao Zuo, Junfeng Sheng, Sina Lan, Zilong Zhao, Shuang Dong, Sheng Hu, Chen Xin, Mingqian Feng
Chimeric antigen receptor (CAR)-modified T cell therapy has achieved remarkable efficacy in treating hematological malignancies, but it confronts many challenges in treating solid tumors, such as the immunosuppressive microenvironment of the solid tumors. These factors reduce the antitumor activity of CAR-T cells in clinical trials. Therefore, we used the immunocytokine interleukin-12(IL-12) to enhance the efficacy of CAR-T cell therapy. In this study, we engineered CAR-IL12R54 T cells that targeted mesothelin (MSLN) and secreted a single-chain IL-12 fused to a scFv fragment R54 that recognized a different epitope on mesothelin...
April 17, 2024: Pharmacological Research: the Official Journal of the Italian Pharmacological Society
https://read.qxmd.com/read/38640255/co-targeting-ebv-lytic-as-well-as-latent-cycle-antigens-increases-t-cell-potency-against-lymphoma
#14
JOURNAL ARTICLE
Sandhya Sharma, Naren U Mehta, Tim Sauer, Dirk P Dittmer, Lisa A Rollins, Cliona M Rooney
The remarkable efficacy of Epstein-Barr virus (EBV) specific T-cells for the treatment of post-transplant lymphomas (PTLD) has not been reproduced for EBV+ malignancies outside the transplant setting. This is due in part to the heterogeneous expression and poor immunogenicity of the viral antigens expressed, namely LMPs 1 and 2, EBNA1, and BARF1 (type-2 (T2) latency). However, EBV lytic cycle proteins are also expressed in certain EBV+ malignancies, and since several EBV lytic cycle proteins are abundantly expressed, have oncogenic activity, and likely contribute to malignancy, we sought and identified viral lytic-cycle transcripts in EBV+ Hodgkin's lymphoma biopsies...
April 19, 2024: Blood Advances
https://read.qxmd.com/read/38640147/the-rebirth-of-epitope-based-patent-claims
#15
REVIEW
Ulrich Storz
BACKGROUND: Patent protection of therapeutic antibodies and T cell receptors is an important tool to enable the path to the market. In view of the substantial spendings for R&D and regulatory approval, sponsors expect exclusivity for their drug for a given period of time. Different categories exist to protect therapeutic antibodies and T cell receptors. One of these categories are epitope-based patent claims, with regard to which in the different jurisdictions, different patentability standards exist, which, furthermore, are constantly changed by courts and lawmakers...
April 1, 2024: Human Antibodies
https://read.qxmd.com/read/38639426/comparative-analysis-of-tropomyosin-allergenicity-in-three-different-species-of-molluscs-insights-into-the-role-of-amino-acid-composition-in-ige-epitopes
#16
JOURNAL ARTICLE
Xinyu Han, Xinrong He, Xinya Wang, Lianzhong Luo, Yubao Li, Dong Lai, Hong Liu, Jingwen Liu, Shitao Rao, Guangming Liu
Limited research has been conducted on the differences in allergenicity among Alectryonella plicatula tropomyosin (ATM), Haliotis discus hannai tropomyosin (HTM), and Mimachlamys nobilis tropomyosin (MTM) in molluscs. Our study aimed to comprehensively analyze and compare their immunoreactivity, sensitization, and allergenicity while simultaneously elucidating the underlying molecular mechanisms involved. We assessed the immune binding activity of TM utilizing 86 sera from allergic patients and evaluated sensitization and allergenicity through two different types of mouse models...
April 19, 2024: Food & Function
https://read.qxmd.com/read/38638120/clinical-relevance-of-hla-dq-eplet-mismatch-and-maintenance-immunosuppression-with-risk-of-allosensitization-after-kidney-transplant-failure
#17
JOURNAL ARTICLE
Jenny Tran, Ibrahim Alrajhi, Doris Chang, Karen R Sherwood, Paul Keown, Jagbir Gill, Matthew Kadatz, John Gill, James H Lan
The optimal immunosuppression management in patients with a failed kidney transplant remains uncertain. This study analyzed the association of class II HLA eplet mismatches and maintenance immunosuppression with allosensitization after graft failure in a well characterized cohort of 21 patients who failed a first kidney transplant. A clinically meaningful increase in cPRA in this study was defined as the cPRA that resulted in 50% reduction in the compatible donor pool measured from the time of transplant failure until the time of repeat transplantation, death, or end of study...
2024: Frontiers in Genetics
https://read.qxmd.com/read/38636332/sa-ttca-an-svm-based-approach-for-tumor-t-cell-antigen-classification-using-features-extracted-from-biological-sequencing-and-natural-language-processing
#18
JOURNAL ARTICLE
Thi-Oanh Tran, Nguyen Quoc Khanh Le
Accurately predicting tumor T-cell antigen (TTCA) sequences is a crucial task in the development of cancer vaccines and immunotherapies. TTCAs derived from tumor cells, are presented to immune cells (T cells) through major histocompatibility complex (MHC), via the recognition of specific portions of their structure known as epitopes. More specifically, MHC class I introduces TTCAs to T-cell receptors (TCR) which are located on the surface of CD8+ T cells. However, TTCA sequences are varied and lead to struggles in vaccine design...
April 4, 2024: Computers in Biology and Medicine
https://read.qxmd.com/read/38635656/design-development-and-validation-of-multi-epitope-proteins-for-serological-diagnosis-of-zika-virus-infections-and-discrimination-from-dengue-virus-seropositivity
#19
JOURNAL ARTICLE
Samille Henriques Pereira, Mateus Sá Magalhães Serafim, Thaís de Fátima Silva Moraes, Nathalia Zini, Jônatas Santos Abrahão, Maurício Lacerda Nogueira, Jordana Grazziela Alves Coelho Dos Reis, Flávia Fonseca Bagno, Flávio Guimarães da Fonseca
Zika virus (ZIKV), an arbovirus from the Flaviviridae family, is the causative agent of Zika fever, a mild and frequent oligosymptomatic disease in humans. Nonetheless, on rare occasions, ZIKV infection can be associated with Guillain-Barré Syndrome (GBS), and severe congenital complications, such as microcephaly. The oligosymptomatic disease, however, presents symptoms that are quite similar to those observed in infections caused by other frequent co-circulating arboviruses, including dengue virus (DENV)...
April 2024: PLoS Neglected Tropical Diseases
https://read.qxmd.com/read/38635553/validation-of-two-immunoassays-for-oxytocin-measurements-in-human-saliva
#20
JOURNAL ARTICLE
Marina López-Arjona, José Joaquín Cerón, Sandra V Mateo, María Dolores Contreras-Aguilar, Silvia Martínez-Subiela
The objective of this research was to develop and validate two immunoassays for oxytocin measurement in human saliva, one using a monoclonal and the other a polyclonal antibody against oxytocin, whose affinity for oxytocin was tested by an antibody mapping epitope analysis. These assays were analytically validated and used to compare oxytocin concentrations with those obtained with a commercial kit before and after the extraction or reduction/alkylation (R/A) treatments to saliva samples. The assays were also used to evaluate changes in salivary oxytocin concentrations following a physical effort and an induced psychological stress, which have previously been described as situations that cause an increase in salivary oxytocin...
2024: PloS One
keyword
keyword
42605
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.